The chief goal of cancer therapeutics has been the discovery of exploitable differences between cancer and normal cells, to allow for selective toxicity. Sixty years of intensive research have largely been an exercise in futility. However, cancer cannot exist without a blood supply and there is ample evidence of very important differences between embryonic and tumor vasculature, on one hand, and the vasculature of mature, adult tissues, on the other hand 1 . Better tools are needed for studying, understanding, and exploiting these differences.
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Calcium influx and intracellular calcium release are felt to modulate endothelial cell proliferation, but sustained calcium influx has also been shown to be associated with endothelial cell death 2-5 . We previously described a novel method for detecting endothelial cell death in primary cell cultures prepared from fresh biopsy specimens of human tumors and from peripheral blood 6 . We report here that the distinctive cytological staining of dead endothelial cells observed in our method is the result of calcium accumulation and that staining for calcium (in the present case, with Alizarin red S) affords a sensitive method for detecting endothelial cell death in vitro. Figure 1 shows the distinctive cytologic appearance of of fresh human tumors which were cultured without and with bevacizumab (2.5 mg/ml, which is a concentration sufficient to remove all detectable VEGF from cell culture supernatants 6) . Dead endothelial cells have a distinctive hyperchromatic, blue-black appearance following the addition of the dye Fast Green to the culture medium, followed by Cytocentrifugation onto microscope slides, followed by counterstaining with Hematoxylin-eosin. Hematoxylin is known to form a blue-black "lake" effect, in the presence of calcium 7 . This staining, at least in dead endothelial cells, is markedly accentuated by preincubation with Fast Green, in our experience.
In the earlier publication 6 , we speculated that the distinctive dead endothelial cell staining was owing to the dye exclusion principle, wherein living cells, with intact cell membranes, would exclude Fast Green, but that Fast Green penetrated dead cells, with incompetent cell membranes, thereby staining the dead endothelial cells. However, this explanation did not entirely explain the fact that the dead endothelial cells stain much more hyperchromatically and appeared to be refractile, in some cases, and even to have a crystalline appearance, in other cases (Figure 2 ). We suspected that the distinctive staining of the dead endothelial cells might be owing to a calcium effect.
We then cultured fresh human tumors and normal peripheral blood (contains circulating endothelial cells) in the presence and absence of bevacizumab and prepared Cytospin slides with Fast Green/Hematoxylin-eosin, Fast Green/Wright-Giemsa, Fast Green/ Alizarin red S (reasonably specific for calcium http://www.ihcworld.com/_protocols/ special_stains/alizarin_red_s.htm), Alizarin red S alone, and Alizarin red S, followed by Wright-Giemsa. Figure 3 shows the dramatic difference between control and bevacizumab-exposed tumor cultures. The distinction between Alizarin red S and background material was greatest (from the standpoint of image analysis) when cells were first sedimented onto microscope slides, air dried, and stained only with Alizarin red S, and then photographed, without coverslips, for image analysis ( Figure 3C , Table 1) . These slides could then be coverslipped, with or without subsequent counterstaining with WrightGiemsa (counterstaining with Hematoxylin-eosin or Hematoxylin alone had the effect of bleaching out the Alizarin red S stain).
There are currently no convenient, sensitive, specific methods for testing the effect of putative anti-angiogenic agents on human tumor-associated human endothelial cells, either generally or on an individual patient basis. Our present method affords such a method. For the purpose of high-throughput studies, one could test circulating peripheral blood endothelial cells from cancer patients (in whom circulating endothelial cells are often increased [8] [9] [10] [11] and which originate, presumably, from tumor-associated capillaries) compared to endothelial cells from peripheral blood from normal volunteers, using simple, public domain image analysis software (http://rsbweb.nih.gov/ij/ ), and the Octospot cytocentrifuge system (http://www.testlaboratories.co.uk/products.asp ).
Furthermore, the present studies suggest that bevacizumab-induced endothelial cell death (almost certainly resulting from VEGF depletion of the cell culture medium 6 ) occurs via a calcium-accumulation mechanism. In addition to bevacizumab, other agents, including protein kinase inhibitors, ethanol, and/or dimethylsulfoxide also produce endothelial cell death in some specimens of human neoplasms through a mechanism which also produces intense calcium staining (most likely signifying calcium accumulation) 6, 12, 13 , with the ethanol/calcium-influx/endothelial death finding supported independently by other evidence, in a different experimental system 4 . Additional support for our findings is the report that VEGF can function as a specific calcium channel blocker 14 . Removal of VEGF (e.g. with bevacizumab) could then lead to calcium entry and endothelial cell death.
In summary: 1.) The mechanism of endothelial cell death in human tumors exposed to bevacizumab and some other agents appears to involve abundant accumulations of calcium. These accumulations occur at levels vastly exceeding those observed in other types of normal and neoplastic cells, making calcium accumulation a sensitive and relatively specific marker for dead endothelial cells in primary human cell culture. Furthermore, perturbation of endothelial calcium influx affords a potential mechanism to augment the effect of agents such as bevacizumab. 2.) Calcium staining using our methodologies provides a convenient means for identifying and studying therapeutic agents targeting endothelial cells. Following culture, cells were stained with Fast Green/Wright-Giemsa, according to previously-described methods 5 , or were stained with Alizarin red S (http:// www.urmc.rochester.edu/path/zqu/StainsManual/index.html?DAHLSMETHODFORCALCIUM ). Bevacizumab, bortezomib, and DMSO/ethanol produced blue-black stained,often highly refractile features and surrounding blue-black "lakes" which are thought to represent dead endothelial cells. Traditional cytotoxic agents (e.g. epirubicin, fludarabine) kill neoplastic cells, generally without producing the blue-black refractile features and lakes. Staining with Alizarin red S, followed by counterstaining with Wright-Giemsa, reveals that the blue-black, refractile features contain heavily concentrated calcium. 
